Transferrin- and folate-modified, double-targeted nanocarriers for gene delivery

References

• Atkinson H, Chalmers R. (2010). Delivering the goods: Viral and non-viral gene therapy systems and the inherent limits on cargo DNA and internal sequences. Genetica 138:485–98
   PubMed Web of Science ®Google Scholar
• Bellocq NC, Pun SH, Jensen GS, Davis ME. (2003). Transferrin-containing, cyclodextrin polymer-based particles for tumor-targeted gene delivery. Bioconjug Chem 14:1122–32
   PubMed Web of Science ®Google Scholar
• Boulaiz H, Marchal JA, Prados J, et al. (2005). Non-viral and viral vectors for gene therapy. Cell Mol Biol (Noisy-le-grand) 51:3–22
   PubMed Web of Science ®Google Scholar
• Choi JS, Ko KS, Park JS, et al. (2006). Dexamethasone conjugated poly(amidoamine) dendrimer as a gene carrier for efficient nuclear translocation. Int J Pharm 320:171–8
   PubMedGoogle Scholar
• Endres T, Zheng M, Beck-Broichsitter M, et al. (2012). Optimising the self-assembly of siRNA loaded PEG-PCL-lPEI nano-carriers employing different preparation techniques. J Control Release 160:583–91
   PubMed Web of Science ®Google Scholar
• Fields RJ, Cheng CJ, Quijano E, et al. (2012). Surface modified poly(β amino ester)-containing nanoparticles for plasmid DNA delivery. J Control Release 3659:00708–10
   Google Scholar
• Jing F, Li J, Liu D, et al. (2013). Dual ligands modified double targeted nano-system for liver targeted gene delivery. Pharm Biol 51:643–9
   PubMed Web of Science ®Google Scholar
• Kim SK, Park KM, Singha K, et al. (2010). Galactosylated cucurbituril-inclusion polyplex for hepatocyte-targeted gene delivery. Chem Commun (Camb) 46:692–4
   PubMed Web of Science ®Google Scholar
• Li P, Liu D, Miao L, et al. (2012). A pH-sensitive multifunctional gene carrier assembled via layer-by-layer technique for efficient gene delivery. Int J Nanomed 7:925–39
   PubMed Web of Science ®Google Scholar
• Liu C, Yu W, Chen Z, et al. (2011). Enhanced gene transfection efficiency in CD13-positive vascular endothelial cells with targeted poly(lactic acid)-poly(ethylene glycol) nanoparticles through caveolaemediated endocytosis. J Control Release 151:162–75
   PubMed Web of Science ®Google Scholar
• Lukyanov AN, Gao Z, Mazzola L, Torchilin VP. (2002). Polyethylene glycoldiacyllipid micelles demonstrate increased acculumation in subcutaneous tumors in mice. Pharm Res 19:1424–9
   PubMed Web of Science ®Google Scholar
• Maruyama K. (2011). Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects. Adv Drug Deliv Rev 63:161–9
   PubMed Web of Science ®Google Scholar
• Paulos CM, Reddy JA, Leamon CP, et al. (2004). Ligand binding and kinetics of folate receptor recycling in vivo: Impact on receptor-mediated drug delivery. Mol Pharmacol 66:1406–14
   PubMed Web of Science ®Google Scholar
• Penate Medina O, Haikola M, Tahtinen M, et al. (2011). Liposomal tumor targeting in drug delivery utilizing MMP-2- and MMP-9-binding ligands. J Drug Deliv 2011:160515
   PubMedGoogle Scholar
• Pinti M, Troiano L, Nasi M, et al. (2003). Hepatoma HepG2 cells as a model for in vitro studies on mitochondrial toxicity of antiviral drugs: Which correlation with the patient? J Biol Regul Homeost Agents 17:166–71.
   PubMed Web of Science ®Google Scholar
• Reddy JA, Abburi C, Hofland H, et al. (2002). Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors. Gene Ther 9:1542–50
   PubMed Web of Science ®Google Scholar
• Sawant RM, Hurley JP, Salmaso S, et al. (2006). “SMART” drug delivery systems: Double-targeted pH-responsive pharmaceutical nanocarriers. Bioconjug Chem 17:943–9
   PubMed Web of Science ®Google Scholar
• Singh M. (1999). Transferrin as a targeting ligand for liposomes and anticancer drugs. Curr Pharm Des 5:443–51
   PubMed Web of Science ®Google Scholar
• Suzuki R, Takizawa T, Kuwata Y, et al. (2008). Effective anti-tumor activity of oxaliplatin encapsulated in transferrin-PEG-liposome. Int J Pharm 346:143–50
   PubMed Web of Science ®Google Scholar
• Torchilin VP. (2005). Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 4:145–60
   PubMed Web of Science ®Google Scholar
• Torchilin VP. (2006). Multifunctional nanocarriers. Adv Drug Deliv Rev 58:1532–55
   PubMed Web of Science ®Google Scholar
• Torchilin VP. (2007) Micellar nanocarriers: Pharmaceutical perspectives. Pharm Res 24:1–16
   PubMed Web of Science ®Google Scholar
• van Vlerken LE, Vyas TK, Amiji MM. (2007). Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery. Pharm Res 24:1405–14
   PubMed Web of Science ®Google Scholar
• Yang L, Wang L, Su XQ, et al. (2010) Suppression of ovarian cancer growth via systemic administration with liposome-encapsulated adenovirus-encoding endostatin. Cancer Gene Ther 17:49–57
   PubMed Web of Science ®Google Scholar
• Yu W, Liu C, Liu Y, et al. (2010). Mannan-modified solid lipid nanoparticles for targeted gene delivery to alveolar macrophages. Pharm Res 27:1584–96
   PubMed Web of Science ®Google Scholar
• Zhao XB, Lee RJ. (2004) Tumor-selective targeted delivery of genes and antisense oligodeoxyribonucleotides via the folate receptor. Adv Drug Deliv Rev 56:1193–204
   PubMed Web of Science ®Google Scholar